balkan myeloma study group: extramedullary disease
Published 4 years ago • 86 plays • Length 3:30Download video MP4
Download video MP3
Similar videos
-
1:41
treating and understanding the biology of extramedullary disease in myeloma
-
1:50
molecular characteristics of extramedullary myeloma
-
1:08
the impact of extramedullary multiple myeloma on outcomes with ide-cel
-
0:59
defining the origins of multiple myeloma
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
2:20
ultra high-risk myeloma
-
0:48
final analysis of the dreamm-2 trial: belantamab mafodotin for r/r multiple myeloma
-
11:22
reading a complete blood count (cbc) and anemia [blood histology 3 of 3]
-
45:25
hematology 101
-
31:30
2019 multiple myeloma symposium | diagnosis, prognosis & risk
-
2:44
the global expansion of modern aml therapy through the international consortium on acute leukemia
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
1:46
insights into mass spectrometry-based proteomics in multiple myeloma research
-
2:16
will car-t be best when used in early relapse in myeloma?
-
1:22
an all-molecular diagnostic approach for myeloma
-
3:56
real-world analysis of treatment patterns and outcomes in newly diagnosed myeloma
-
1:30
real-world insight for myeloma
-
0:46
future developments in myeloma treatment
-
1:07
how covid-19 has impacted clinical practice and treatment approaches in multiple myeloma
-
1:30
exploring the role of upfront autosct in multiple myeloma
-
2:09
advancing cml treatment: novel drugs, personalized treatment strategies, and improving tfr
-
1:24
triple-negative myelofibrosis: disease features and outcomes